About Course
Global prevalence of end-stage Chronic kidney disease (approx. 9.1%) is growing andwith co-existent diabetes and hypertension leading to a triple-health threat and anexemplar of the global health challenge from multi-morbidity. There is emerging evidenceand paucity of knowledge where a significant proportion of patients fail to meet treatmenttargets despite the promulgation of improved guidelines. In this CME, we address thehighly complex inter-related nature of CKD and Cardio-diabetes, focus on...



